NATIONAL HEALTHCARE (NHC) stock: insider trades, news & valuation
Net sellingShare price and insider trades
NATIONAL HEALTHCARE insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $175K and 9 sold $11.2M of NHC stock on the open market.
Get emailed when insiders cluster-buy stocks like NHC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
NHC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $5.6M | 15 |
| Q2 2026 | $175K | 1 | $3.3M | 4 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $2.2M | 4 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 NATIONAL HEALTHCARE CORP insider reported open-market purchases totaling $175K, while 9 insiders reported sales totaling $11.2M. 0 of 23 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 23SEC | Vicki L DodsonSr.Vp Patient Srvcs | Sell | 4,83410,726 held (−31%) | $225.00 | $1.1M | +0.9% | — |
| Sep 14SEC | Brian F KiddCFO | Sell | 6,81323,183 held (−23%) | $225.70 | $1.5M | +0.6% | — |
| Sep 14SEC | Josh A MccrearyGeneral Counsel | Sell | 1,29110,047 held (−11%) | $225.09 | $291K | +0.9% | — |
| Sep 14SEC | Josh A MccrearyGeneral Counsel | Sell | 78911,338 held (−7%) | $223.78 | $177K | +1.5% | — |
| Sep 14SEC | Josh A MccrearyGeneral Counsel | Sell | 57112,127 held (−4%) | $222.73 | $127K | +2.0% | — |
| Sep 14SEC | Josh A MccrearyGeneral Counsel | Sell | 689,979 held (−1%) | $225.59 | $15K | +0.7% | — |
| Sep 2SEC | Ben Anderson Flatt Sr.Senior Vp & Cio | Sell | 1,00018,636 held (−5%) | $237.18 | $237K | -4.2% | — |
| Sep 2SEC | Ben Anderson Flatt Sr.Senior Vp & Cio | Sell | 1,00017,636 held (−5%) | $237.00 | $237K | -4.2% | — |
| Sep 2SEC | Ben Anderson Flatt Sr.Senior Vp & Cio | Sell | 1,00016,636 held (−6%) | $227.00 | $227K | +0.0% | — |
| Sep 2SEC | Ben Anderson Flatt Sr.Senior Vp & Cio | Sell | 1,00019,636 held (−5%) | $226.00 | $226K | +0.5% | — |
| Sep 2SEC | Ben Anderson Flatt Sr.Senior Vp & Cio | Sell | 1,00015,636 held (−6%) | $222.50 | $222K | +2.1% | — |
| Sep 2SEC | Ben Anderson Flatt Sr.Senior Vp & Cio | Sell | 1,00020,636 held (−5%) | $222.11 | $222K | +2.3% | — |
| Sep 2SEC | Ben Anderson Flatt Sr.Senior Vp & Cio | Sell | 1,00021,636 held (−4%) | $221.21 | $221K | +2.7% | — |
| Aug 28SEC | David R. GiffordDirector | Sell | 1,7791,030 held (−63%) | $225.42 | $401K | +0.7% | — |
| Aug 20SEC | Stephen Fowler FlattCEO | Sell | 1,50065,487 held (−2%) | $237.08 | $356K | -4.2% | — |
| Jun 23SEC | Emil E HassanDirector | Sell | 5,93765,595 held (−8%) | $200.00 | $1.2M | +13.6% | — |
| Jun 18SEC | Emil E HassanDirector | Sell | 1,56371,532 held (−2%) | $199.98 | $313K | +13.6% | — |
| Jun 2SEC | Lisa PierceyDirector | Buy | 949new position | $184.26 | $175K | +23.3% | — |
| May 22SEC | Richard F Laroche Jr.Director | Sell | 7,500205,760 held (−4%) | $195.14 | $1.5M | +16.4% | — |
| May 20SEC | Timothy J. ShellySr.Vp Operations | Sell | 1,8531,294 held (−59%) | $197.22 | $365K | +15.2% | — |
| Dec 18SEC | Timothy J. ShellySr.Vp Operations | Sell | 2,454 | $139.42 | $342K | +62.9% | — |
| Nov 26SEC | Emil E HassanDirector | Sell | 7,50065,595 held (−10%) | $138.52 | $1.0M | +64.0% | — |
| Nov 25SEC | Stephen Fowler FlattCEO | Sell | 1,00059,130 held (−2%) | $130.33 | $130K | +74.3% | — |
| Nov 12SEC | Emil E HassanDirector | Sell | 5,50073,095 held (−7%) | $133.00 | $732K | +70.8% | — |
Insiders at NATIONAL HEALTHCARE CORP
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Emil E HassanDirector | — | $3.3M | Jun 23, 2026 | — |
| Ben Anderson Flatt Sr.Senior Vp & Cio | — | $1.6M | Sep 2, 2026 | — |
| Brian F KiddCFO | — | $1.5M | Sep 14, 2026 | — |
| Richard F Laroche Jr.Director | — | $1.5M | May 22, 2026 | — |
| Vicki L DodsonSr.Vp Patient Srvcs | — | $1.1M | Sep 23, 2026 | — |
| Timothy J. ShellySr.Vp Operations | — | $708K | May 20, 2026 | — |
| Josh A MccrearyGeneral Counsel | — | $610K | Sep 14, 2026 | — |
| Lisa PierceyDirector | $175K | — | Jun 2, 2026 | — |
| Stephen Fowler FlattCEO | — | $486K | Aug 20, 2026 | — |
| David R. GiffordDirector | — | $401K | Aug 28, 2026 | — |
NHC stock: common questions
Are NATIONAL HEALTHCARE CORP insiders buying NHC stock?
In the past 12 months, 1 insiders reported open-market purchases of NHC worth $175K. The latest was Director Lisa Piercey bought $175K of NHC at $184.26 — first open-market purchase in our records; opens a new position.
Are NATIONAL HEALTHCARE CORP insiders selling NHC stock?
9 insiders reported sales worth $11.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NHC's 52-week range?
Over the past year NHC has traded between $115.70 and $236.04. It last closed at $227.11 on Oct 9, 2026.